You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 24, 2025

Drug Price Trends for ACID REDUCER COMPLETE TAB CHEW


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for ACID REDUCER COMPLETE TAB CHEW

Average Pharmacy Cost for ACID REDUCER COMPLETE TAB CHEW

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ACID REDUCER COMPLETE TAB CHEW 70000-0416-01 0.25827 EACH 2025-03-19
ACID REDUCER COMPLETE TAB CHEW 70000-0582-01 0.25827 EACH 2025-03-19
ACID REDUCER COMPLETE TAB CHEW 70000-0416-01 0.25487 EACH 2025-02-19
ACID REDUCER COMPLETE TAB CHEW 70000-0582-01 0.25487 EACH 2025-02-19
ACID REDUCER COMPLETE TAB CHEW 70000-0416-01 0.25562 EACH 2025-01-22
ACID REDUCER COMPLETE TAB CHEW 70000-0582-01 0.25562 EACH 2025-01-22
ACID REDUCER COMPLETE TAB CHEW 70000-0416-01 0.25773 EACH 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Acid Reducer Complete Tab Chew

Introduction to Acid Reducer Complete Tab Chew

Acid Reducer Complete Tab Chew, such as Pepcid Complete, is a dual-action medication designed to provide quick and lasting relief from heartburn, acid indigestion, and sour stomach. These chewable tablets combine a fast-working antacid with a long-lasting acid reducer, making them a popular choice for managing gastrointestinal discomfort.

Market Size and Growth

The global acid reducer market, which includes products like Pepcid Complete, is projected to experience significant growth. As of 2023, the market is valued at approximately $23.1 billion and is expected to expand at a Compound Annual Growth Rate (CAGR) of 5.7% to reach $40.3 billion by 2033[3][4].

Key Drivers of Market Growth

  • Increasing Geriatric Population: The elderly population is more prone to gastrointestinal issues such as GERD and peptic ulcers, driving the demand for acid reducers. By 2050, Asia alone is expected to have 923 million people over the age of 60, contributing significantly to this demand[3].
  • Changing Dietary Trends and Sedentary Lifestyle: The rise in sedentary lifestyles and consumption of junk food has led to an increase in obesity and persistent gastrointestinal issues, further boosting the demand for acid reducers[4].
  • Availability of OTC Products: The ease of access to over-the-counter (OTC) acid reducers has significantly contributed to market growth. OTC products accounted for more than 50% of the overall market share in 2022[4].

Regional Market Analysis

North America

The North American market for acid reducers is anticipated to grow at a CAGR of 5.5% during the forecast period. This growth is driven by the high prevalence of GERD and peptic ulcer disease, as well as lenient regulations on OTC drugs. North America accounts for around 18% to 28% of the global GERD prevalence[4].

Europe

Europe holds a significant market share, accounting for approximately 31.7% of the global acid reducer market in 2022. The region is expected to experience rapid expansion at a CAGR of 4.8% due to the rising incidence of digestive problems and the availability of advanced treatment and diagnostic facilities[4].

Product Form and Preferences

Acid Reducer Tablets

Acid reducer tablets, including chewable forms like Pepcid Complete, hold the largest market share. These tablets are preferred due to their ease of use, storage, and handling. They are also the cheapest oral dosage form and have a longer shelf life compared to other forms, contributing to their popularity[4].

Pricing and Availability

Current Pricing

Pepcid Complete Acid Reducer + Antacid Chewable Tablets are available in various pack sizes and flavors. For example, a 50-count bottle can be purchased for around $25.99, while a 25-count bottle may cost approximately $17.99[2][5].

Price Projections

Given the growing demand and expanding market, prices for acid reducer products are likely to remain competitive. However, there could be slight increases due to rising production costs and advancements in formulation. Here are some potential price trends:

  • Short-term: Prices are expected to remain stable due to high competition in the OTC market.
  • Medium-term: There might be a slight increase in prices as manufacturers invest in product development and marketing.
  • Long-term: With the market expected to grow significantly, prices could stabilize or see minor adjustments based on market dynamics and regulatory changes.

Consumer Behavior and Preferences

Consumers increasingly prefer OTC products for their convenience and ease of access. The trend towards self-medication and the availability of products through online channels have significantly influenced purchasing behavior. Here are some key consumer preferences:

  • Fast-acting Relief: Consumers seek products that provide quick relief from heartburn and indigestion, making dual-action products like Pepcid Complete highly appealing[1][2][5].
  • Convenience: Chewable tablets are preferred for their ease of use and smooth texture, which is not chalky or gritty[2][5].
  • Affordability: The affordability of acid reducer tablets is a crucial factor, with consumers often opting for the cheapest yet effective oral dosage form[4].

Key Takeaways

  • The global acid reducer market is projected to grow at a CAGR of 5.7% from 2023 to 2033.
  • The geriatric population and changing dietary trends are key drivers of market growth.
  • North America and Europe are significant markets, driven by high GERD prevalence and advanced healthcare facilities.
  • Acid reducer tablets, especially chewable forms, hold the largest market share due to their convenience and affordability.
  • Prices are expected to remain competitive with potential minor increases due to market dynamics.

FAQs

Q: What are the main ingredients in Pepcid Complete Acid Reducer + Antacid Chewable Tablets?

A: Each tablet contains 10 mg of famotidine (an acid reducer), 800 mg of calcium carbonate, and 165 mg of magnesium hydroxide (both antacids)[1][2][5].

Q: How quickly do Pepcid Complete tablets start working?

A: These tablets start relieving indigestion in seconds and provide effective heartburn relief that lasts all day or all night based on 9-hour daytime and 12-hour nighttime studies[1][2][5].

Q: What is the projected market value of the global acid reducer market by 2033?

A: The global acid reducer market is expected to reach $40.3 billion by 2033[3][4].

Q: Which region dominates the global acid reducer market?

A: Europe dominates the global acid reducer market with a significant market share, expected to grow at a CAGR of 4.8% during the forecast period[4].

Q: Why are acid reducer tablets the most popular form of acid reducers?

A: Acid reducer tablets are preferred due to their ease of use, storage, and handling, as well as their affordability and longer shelf life compared to other forms[4].

Sources

  1. Target: Pepcid Ac Complete Tablets Mint - 50ct.
  2. Optum: Pepcid Complete Acid Reducer + Antacid Chewable Tablets, Berry.
  3. GlobeNewswire: Mounting Calls for Generic & Over-the-counter Medications for Gastrointestinal Disorders to Drive Acid Reducer Market Growth.
  4. Fact.MR: Acid Reducer Market Size, Trends and Forecast 2023 to 2033.
  5. SchoolHealth: Pepcid Complete Acid Reducer + Antacid, Chewable Tablets, Berry.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.